ArticleJournal of the American Geriatrics Society2026
Outcomes After Percutaneous Coronary Intervention for Chronic Coronary Disease in Adults ≥ 75 versus < 75 Years.
Article in Journal of the American Geriatrics Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundWhile PCI is widely used for chronic coronary disease (CCD), older adults (≥ 75 years) face distinct procedural risks, and their outcomes compared with younger patients remain incompletely understood.
methodsWe investigated age-related differences in health outcomes following PCI for CCD using Vizient Clinical Data Base that includes both inpatient and outpatient PCI. Vizient aggregates clinical and outcome data from over 97% of U.S. academic medical centers and 1000+ community hospitals. We included all patients that underwent PCI for CCD between January 2016 and June 2022. The primary outcome was the occurrence of major adverse cardiovascular events (MACE). After propensity-score matching older (≥ 75 years) and younger (< 75 years) adults, we analyzed major adverse cardiovascular events (MACE) in the year following index PCI using Kaplan-Meier curves. Relative risks (RR) were calculated using Zou's modified Poisson approach. Secondary outcomes included all-cause mortality, repeat PCI, major bleeding, and cardiovascular-related hospitalizations.
resultsA total of 176,492 patients were included. 70.5% of patients were < 75 years old, while 29.5% were ≥ 75 years old. Most PCIs for CCD occurred in the outpatient setting (51.0%), followed by inpatient (28.6%), observation (17.1%), and other (3.3%) settings. Older adults experienced lower adjusted risk of MACE (relative risk [RR] 0.93, 95% confidence interval [CI] 0.89-0.96), as well as MI or repeat PCI, compared with younger adults. They experienced higher risk of hospitalization for a cardiovascular cause (RR 1.40, 95% CI 1.36-1.44). No significant difference was observed in the risk of all-cause mortality or major bleeding.
conclusionAfter adjusting for baseline differences, older adults who undergo PCI for CCD have a risk of MACE and major bleeding that is comparable to younger patients. However, older adults do experience higher rates of subsequent cardiovascular hospitalizations following PCI for CCD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.